Director Holroyd Samantha bought 1,250 shares of CHRD at $85.50; stock now -35.1% from 52-week high, director's prior CHRD buy showed -11.5% 90-day return.
Director Samantha Holroyd purchased 1,250 shares at $85.50 on 2025-11-07, increasing her holdings by 7.6% to 17,706 shares. The timing appears unfavorable relative to recent price momentum: the stock trades at $87.26, down 3.7% over 30 days and 12.8% over 90 days, and sits 35.1% below its 52-week high of $134.43. More notably, Holroyd's single prior transaction at CHRD—a buy on 2024-08-23—produced a 90-day return of -11.5%, and across her cross-ticker open-market history she has achieved a 0% 90-day win rate with an average 90-day return of -11.5%. The fundamental backdrop shows the company has grown revenue 34.8% annually with a P/E of 29.09 and market cap of $4.0B, but the director's historical execution at this ticker provides little reassurance that the current entry point will prove well-placed in the near term.